Get started
Avenue Therapeutics, Inc.Avenue Therapeutics, Inc.Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

ATXI chart

Key stats

Market capitalization
‪5.53 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.7809USD
Net income
‪−10.38 M‬USD
Revenue
—
Shares float
‪39.43 M‬
Beta (1Y)
−0.46

About Avenue Therapeutics, Inc.

Sector
Health Technology
CEO
Alexandra MacLean
Headquarters
Bay Harbor Islands
Website
avenuetx.com
Employees (FY)
3
Founded
2015
ISIN
US05360L3042
FIGI
BBG00GLTS4V4
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ATXI is 0.13 USD — it has increased by 3.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Avenue Therapeutics, Inc. stocks are traded under the ticker ATXI.
Avenue Therapeutics, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Avenue Therapeutics, Inc. has a max estimate of 0.75 USD and a min estimate of 0.75 USD.
ATXI earnings for the last quarter are 0.06 USD whereas the estimation was −0.26 USD which accounts for 123.08% surprise. Estimated earnings for the next quarter are −0.10 USD. See more details about Avenue Therapeutics, Inc. earnings.
Yes, you can track Avenue Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ATXI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avenue Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ATXI reached its all-time high on Sep 14, 2020 with the price of 185.10 USD, and its all-time low was 0.11 USD and was reached on Feb 7, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 3.00 employees. See our rating of the largest employees — is Avenue Therapeutics, Inc. on this list?